Mineralys Therapeutics upsized its IPO, raising capital to finance clinical trial plans for a molecule that could become an alternative to currently available hypertension medicines. The Mineralys molecule takes a similar approach to a drug candidate that AstraZeneca is acquiring in a $1.3 billion deal.
CardieX, a cardiovascular technology company based in both Australia and Illinois, recently acquired Blumio, a San Mateo, California-based startup focused on cardiovascular sensors. The deal will advance both companies’ vision to accurately and easily measure blood pressure without relying on the use of a cuff.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The Series D funding round was led by growth equity firm Stripes. Hello Heart's latest haul brings the total amount the company has raised since its founding in 2013 to $138 million.
A large study published in JAMA Network Open found that people with stage II hypertension were able to reduce their systolic blood pressure and maintain it over three years using Hello Heart’s app.
According to a report by the Wall Street Journal, Apple is planning to add more health features to its watch, including a feature to track blood pressure and a wrist-based thermometer.
Fitbit is launching a trial to see if its its newest smartwatch could use pulse arrival time to measure blood pressure. Other wearable companies have tried to add wrist-based blood pressure features to their devices, but so far, they have limited accuracy.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Providing care for chronic disease patients during a one-in-a-century pandemic is full of challenges, but health systems like Jefferson Health are finding ways — with help from technology — to make sure their patients are getting the care they need.
Livongo has revealed a new voice-enabled blood pressure monitoring system, which is powered by Amazon Lex and Amazon Polly.
The pre-order price of the device is $499 and it will be available in retail stores starting in January.
Every digital health startup wants clinical validation, but studies have unexpected results. That's what appears to have greeted Medisafe when it ventured to gather real-world evidence about its mobile health tool.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Qardio's three products — QardioArm, QardioBase and QardioCore — have been integrated onto Tactio Health Group's digital platform.
The agreement bars Aura Labs and founder Ryan Archdeacon from claiming that the Instant Blood Pressure app is as accurate as a traditional blood pressure cuff.